Release Date: 21/04/09 09:23 Summary: Information Booklet for Shareholders Price Sensitive: Yes Download Document 168.77KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling